Form 4: VolitionRx COO Reports Routine Stock Transaction for Tax Withholding

VolitionRx Ltd.'s Chief Operating Officer, Gaetan Michel, reported a disposition of 7,835 common shares to cover tax obligations related to restricted stock unit settlement.

Summary

• Gaetan Michel, Chief Operating Officer of VolitionRx Ltd. (VNRX), reported a transaction on June 1, 2025.
• The transaction involved the disposition of 7,835 shares of common stock.
• These shares were withheld by VolitionRx for cancellation to satisfy tax withholding obligations arising from the settlement of 15,671 restricted stock units (RSUs).
• The RSUs were awarded to Mr. Michel in lieu of cash compensation.
• The reported price for the shares withheld was $0.503 per share.
• No shares were sold by either Mr. Michel or VolitionRx in this transaction; it was a non-cash settlement for tax purposes.
• Following this transaction, Mr. Michel beneficially owns 380,441 shares of VolitionRx common stock directly.

Sentiment

Score: 5

Explanation: The transaction is neutral as it represents a routine tax withholding event for equity compensation, not a discretionary sale or purchase by the insider.

Positives

• The transaction is a routine tax withholding, indicating the settlement of previously awarded restricted stock units, which is a form of compensation for the COO.
• No actual sale of shares by the COO or the company occurred, meaning the shares were simply cancelled to cover tax liabilities.

Negatives

• The disposition of shares, even for tax purposes, reduces the direct beneficial ownership of the reporting person.

Future Outlook

This SEC Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a standard insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not reflect specific industry trends or competitive dynamics.

Comparison to Industry Standards

• This transaction is a routine disposition of shares to cover tax obligations upon the settlement of restricted stock units, which is a standard and expected event for executives receiving equity compensation across publicly traded companies globally. No specific comparable companies, projects, or results are relevant as this is an individual executive's compensation event.

Stakeholder Impact

• Shareholders: Minor dilution from the RSU settlement, but the tax withholding itself has minimal direct impact beyond the initial RSU grant.

Key Dates

Keywords

VolitionRx, VNRX, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Tax Withholding, Beneficial Ownership, Gaetan Michel, Chief Operating Officer